Sign In
Buy MKGAF
$149.28
-7.84 (-4.99%)
At Close: Jun 22, 2026
Sutro; A Biotech To Watch With A Catalyst Rapidly Approaching
05:32pm, Monday, 27'th Dec 2021
Sutro; A Biotech To Watch With A Catalyst Rapidly Approaching
Merck to Present Latest Highlights From Oncology Portfolio at WCLC and ESMO 2021
06:05pm, Sunday, 12'th Sep 2021
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced research from Company-sponsored, investigator-sponsored, and collaborative studies — including t
Telix and Merck KGaA, Darmstadt, Germany, to Commence Pan-Cancer Clinical Combination Studies
09:02pm, Tuesday, 17'th Aug 2021
MELBOURNE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix', the ‘Company') today announces that it has entered into a pan-cancer clinical collaboratio
Merck KGaA CFO Says More Deals Likely Amid Covid Boom
10:39am, Wednesday, 12'th May 2021
May.12 -- Merck KGaA CFO Marcus Kuhnert discusses the likelihood for a prolonged boom in Covid-19 vaccine and test components, the growing need for more semiconductors and why that means his company w
Merck Announces New Data Strengthening Evidence for Continued Safe and Effective MAVENCLAD® Use During the COVID-19 Pandemic
09:11am, Friday, 23'rd Apr 2021
DARMSTADT, Germany--(BUSINESS WIRE)--Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced a new analysis from the MAGNIFY-MS sub-study showing a sp
